Orexin/Hypocretin System: Obesity, Narcolepsy and Beyond.

Area of Science:

• Neuroscience
• Endocrinology
• Physiology

Background:

• Obesity is a widespread epidemic in industrialized nations.
• Understanding appetite and food-seeking behavior is crucial for developing effective obesity treatments.
• Food-seeking behavior integrates appetite, wakefulness, and sympathetic activity.

Purpose of the Study:

• To explore the role of newly discovered hypothalamic peptides, orexin A and orexin B, in regulating appetite and related systems.
• To investigate the orexin system's potential as a common modulator of appetite, wakefulness, and sympathetic activity.
• To examine the therapeutic potential of targeting the orexin system for obesity, narcolepsy, and cardiovascular disease.

Main Methods:

• Identification and characterization of orexin peptides (orexin A/hypocretin 1 and orexin B/hypocretin 2) in the lateral hypothalamus.
• Analysis of orexin receptor (OX(1)R and OX(2)R) expression throughout the neuraxis.
• Review of physiological studies in animals and humans investigating the role of orexin/hypocretin in food intake, sleep-wake cycles, and autonomic activity.

Main Results:

• Orexin peptides are exclusively found in the lateral hypothalamus.
• Orexin receptors (OX(1)R and OX(2)R) are widely expressed.
• The orexin system plays a significant role in modulating food intake, sleep-wake cycles, and autonomic activity.

Conclusions:

• The orexin system provides a potential common pathway for integrating appetite, wakefulness, and sympathetic activity.
• Understanding the orexin system opens avenues for developing novel therapeutics targeting obesity, narcolepsy, and cardiovascular disease.